FAH Antikörper (N-Term)
Kurzübersicht für FAH Antikörper (N-Term) (ABIN952405)
Target
Alle FAH Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 14-41, N-Term
-
Spezifität
- This antibody recognizes Human Fumarylacetoacetase (N-term).
-
Aufreinigung
- Affinity Chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 14-41 amino acids from the N-terminal region of human FAH
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- FAH (Fumarylacetoacetate Hydrolase (Fumarylacetoacetase) (FAH))
-
Andere Bezeichnung
- Fumarylacetoacetase
-
Hintergrund
- This gene encodes the last enzyme in the tyrosine catabolism pathway. FAH deficiency is associated with Type 1 hereditary tyrosinemia (HT).Synonyms: Beta-diketonase, FAA, FAH, Fumarylacetoacetate hydrolase
-
Molekulargewicht
- 46374 Da
-
Gen-ID
- 2184
-
NCBI Accession
- NP_000128
Target
-